Asthma Drug Slows Down Retinopathy Changes in Type 1 Diabetes

by Ramya Rachamanti on  July 30, 2019 at 6:05 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Asthma medication named montelukast (brand name Singulair) inhibits early changes in diabetic retinopathy in type 1 diabetes, according to the researchers from University Hospitals Rainbow Babies, Children's Hospital and Case Western Reserve University School of Medicine.
Asthma Drug Slows Down Retinopathy Changes in Type 1 Diabetes
Asthma Drug Slows Down Retinopathy Changes in Type 1 Diabetes

The study which was done in a mouse model got published in the journal Diabetes.

Show Full Article


"We found that montelukast (Singulair) was able to disrupt the signaling of inflammatory molecules called leukotrienes. This disruption significantly reduced small blood vessel and nerve damage that we see in the early stages of diabetic retinopathy," said senior author Rose Gubitosi-Klug, M.D., Ph.D., Chief of Pediatric Endocrinology at UH Rainbow and the William T. Dahms Professor of Pediatrics at CWRU School of Medicine.

"While most therapies target the late stages of the eye disease in diabetes, these findings offer a much-needed approach to treat the disease much earlier."

"The re-purposing of a medication already FDA-approved for use in children and adolescents sets the stage for rapid translation of these animal model findings to human subjects," said Dr. Gubitosi-Klug. "The daily dose equivalent used in the current study is similar to the once daily dose used in the treatment of asthma. Reassuringly, in our diabetes model as in asthma studies, this dose allows effective suppression of chronic inflammation, which can prevent pathology, but avoids complete inhibition of inflammation, which can compromise innate immunity."

"Moreover, montelukast was efficacious in both prevention and delayed intervention approaches, which implies relevance to patients with newly-diagnosed diabetes as well as individuals living with diabetes of longer duration," she said. "Thus, there is promise that a safe treatment that effectively stabilizes airways in asthma may also preserve small blood vessels and nerve cells in diabetes."



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

More News on:

Childhood Asthma Diabetic Retinopathy Drug Toxicity Asthma Diabetes Mellitus Diabetes Diabetic Diet Otitis Media Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive